
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain activ... Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.105 | 3 | 3.5 | 3.7413 | 3.3 | 81885 | 3.47936684 | CS |
4 | -5.095 | -58.5632183908 | 8.7 | 9.86 | 3.3 | 586978 | 5.34016531 | CS |
12 | -0.217 | -5.67765567766 | 3.822 | 14.28 | 2.35 | 5397862 | 7.15582622 | CS |
26 | -3.8038 | -51.3416477702 | 7.4088 | 14.28 | 2.35 | 3664164 | 6.58889658 | CS |
52 | -10.815 | -75 | 14.42 | 15.82 | 2.35 | 1910661 | 6.82598382 | CS |
156 | -38.960656 | -91.5307307845 | 42.565656 | 46.48 | 2.35 | 646985 | 7.17353291 | CS |
260 | -205.835 | -98.2787433155 | 209.44 | 273.84 | 2.35 | 690909 | 68.95581575 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.